Addressing the syndemic of HIV, hepatitis C, overdose, and COVID-19 among people who use drugs: the potential roles for decriminalization and safe supply M Bonn, A Palayew, S Bartlett, TD Brothers, N Touesnard, M Tyndall Journal of studies on alcohol and drugs 81 (5), 556-560, 2020 | 126 | 2020 |
“COVID just kind of opened a can of whoop-ass”: The rapid growth of safer supply prescribing during the pandemic documented through an environmental scan of addiction and harm … S Glegg, K McCrae, G Kolla, N Touesnard, J Turnbull, TD Brothers, R Brar, ... International Journal of Drug Policy 106, 103742, 2022 | 48 | 2022 |
A qualitative study on overdose response in the era of COVID-19 and beyond: how to spot someone so they never have to use alone M Perri, N Kaminski, M Bonn, G Kolla, A Guta, AM Bayoumi, ... Harm reduction journal 18, 1-9, 2021 | 47 | 2021 |
Developing a digital health strategy for people who use drugs: Lessons from COVID-19 M Perri, A Guta, M Gagnon, M Bonn, P Leece, AM Bayoumi, N Rai, ... Digital health 7, 20552076211028404, 2021 | 15 | 2021 |
“The times they are a-changin’”: addressing common misconceptions about the role of safe supply in North America’s overdose crisis M Bonn, A Palayew, S Bartlett, TD Brothers, N Touesnard, M Tyndall Journal of studies on alcohol and drugs 82 (1), 158-160, 2021 | 15 | 2021 |
Challenges of implementing safer supply programs in Canada during the COVID-19 pandemic: a qualitative analysis M Karamouzian, B Rafat, G Kolla, K Urbanoski, K Atkinson, G Bardwell, ... International Journal of Drug Policy 120, 104157, 2023 | 11 | 2023 |
Addressing the overdose crisis in North America with bold action G Kolla, N Touesnard, T Gomes Addiction 117 (5), 1194-1196, 2022 | 11 | 2022 |
Securing safe supply during COVID-19 and beyond: Scoping review and knowledge mobilization M Bonn, N Touesnard, B Cheng, M Pugliese, E Comeau, C Bodkin, ... | 11 | 2021 |
Overdose deaths and HIV infections among people who use drugs: shared determinants and integrated responses N Touesnard, TD Brothers, M Bonn, EJ Edelman Expert review of anti-infective therapy 20 (8), 1061-1065, 2022 | 6 | 2022 |
Spotting as a risk mitigation method: a qualitative study comparing organization-based and informal methods M Perri, A Guta, N Kaminski, M Bonn, G Kolla, A Bayoumi, L Challacombe, ... International Journal of Drug Policy 111, 103905, 2023 | 4 | 2023 |
Safe Supply in the Midst of a Crisis of Unregulated Toxic Drug Deaths—A Commentary on Roberts and Humphreys (2023) M Bonn, A Palayew, N Touesnard, TD Brothers, C Bodkin Journal of studies on alcohol and drugs 84 (4), 648-650, 2023 | 1 | 2023 |
A scoping review of ethical considerations when responding to the needs of people who use drugs during public health emergencies: Working paper (search inclusive of August 20th A Guta, C Strike, M Gagnon, K Rudzinski, M Perri, N Touesnard, M Bonn, ... | | |